Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Political novice Renard Johnson's business acumen, community work brings new leadership style to mayor's office.

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement ...

Inc. (GILD) for example. In the following article, I will look at Johnson & Johnson again and try to answer the question if the stock is still a “Buy” at this point. On October 15, 2024 ...

Magic Johnson is now worth an estimated $1.2 billion. His career earnings as a basketball player was $40 million. The magic? He says it comes from—of course—teaming up.

Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...

s disease-related psychosis and agitation Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which ...

Netflix reported better than expected earnings on strong subscriber growth. Meanwhile, Apple is losing market share in China.